Home » Topics » Articles » Insight

Insight
RSS

Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: July 1998

Aug. 31, 1998

Vitravene And Remicade Get Approved; Enbrel May Be Next

Aug. 31, 1998

FDA Submissions, Approvals And Other Actions: July 1998

Aug. 31, 1998

Biotech Product Pipeline Bursting At The Seams

Aug. 24, 1998

Clinical Trial Update: July 1998

Aug. 24, 1998

Venture Capital; PIPE/Reg. S; And Corporate Investments In Biotechnology Companies: July 1998

Aug. 17, 1998

Money Raised By Biotech In 1998: January - July

Aug. 17, 1998

Have Stocks Hit Bottom Yet?

Aug. 17, 1998

Public Financing Of Biotechnology: July 1998

Aug. 17, 1998

Other Financings Of Public Biotechnology Companies: July 1998

Aug. 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...
Genescience presents STAT6 degrader for atopic dermatitis
BioWorld Science
Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....